Effects of Ibuprofen on the physiology and outcome of rabbit endotoxic shock
Tóm tắt
Despite major developments in the management of septic shock, the mortality rate had progressively increased. Ibuprofen has been shown to have beneficial physiological effects when used as a treatment. However, there are conflicting results with respect to survival. This study aims to investigate the effect of ibuprofen on vital functions, various physiological parameters and survival during endotoxic shock in rabbits. Twenty-eight New Zealand rabbits were randomly separated into four groups. The first group received only saline, the second was given 2 mg/kg intravenous endotoxin at t0, the third received 30 mg/kg ibuprofen 30 minutes after endotoxin administration, whilst the fourth group received ibuprofen 30 minutes before the endotoxin. Respiratory and heart rate, mean arterial blood pressure and rectal temperature were recorded. Complete blood counts were performed and thromboxane B2 was measured every 30 minutes for the first two hours, and then hourly over the course of the experiment. Urine samples were collected at the same time points for the measurement of prostaglandin E2. Ibuprofen was found to improve respiratory rate, heart rate, and arterial pressure. However, it did not improve the negative effects of endotoxin on body temperature, haematocrit values, white blood cell count, and thrombocyte number. Thromboxane B2 levels in group IV were significantly lower than in the other groups, and the increase started at a later timepoint. In ibuprofen-treated animals, Prostaglandin E2 levels stayed low for at least 90 minutes, but started to rise thereafter. While the average survival in Group II animals was 192.9 ± 46.9 minutes, those of groups III and IV were 339.1 ± 33.5 minutes (p < 0.05) and 383.0 ± 39.6 minutes (p = 0.01), respectively. Ibuprofen appears to increase survival in endotoxic shock-induced animals. Therefore, it may be helpful for the prophylaxis and treatment of patients with, or who are likely to develop, septic shock.
Tài liệu tham khảo
Hubbard JD, Janssen HF: Increased microvascular permeability in canine endotoxic shock: protective effects of ibuprofen. Circ Shock. 1988, 26 (2): 169-83.
Karima R, Matsumoto S, Higashi H: The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today. 1999, 5 (3): 123-32. 10.1016/S1357-4310(98)01430-0.
Fletcher JR: The effects of ibuprofen on eicosanoid synthesis in sepsis. Crit Care Med. 1999, 27 (4): 669-70.
Griffin MP, Gore DC, Lobe TE, Flynn JF, Traber DL, Herndon DN: Ibuprofen therapy in experimental porcine gram-negative septic shock. Resuscitation. 1991, 22 (1): 75-83.
Jacobs ER, Soulsby ME, Bone RC, Wilson FJ, Hiller FC: Ibuprofen in canine endotoxic shock. J Clin Invest. 1982, 70 (3): 536-41.
Fink MP, MacVittie TJ, Casey LC: Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg. 1984, 200 (5): 619-26.
Hulton NR, Johnson DJ, Willmore DW: Limited effects of prostaglandin inhibitors in Escherichia coli sepsis. Surg. 1985, 98 (2): 291-7.
Coran AG, Drongowski RA, Paik JJ, Remick DG: Ibuprofen intervention in canine septic shock: reduction of pathophysiology without decreased cytokines. J Surg Res. 1992, 53 (3): 272-9.
Herbertson M, Werner H, Studer W, Russell JA, Walley KR: Decreased left ventricular contractility during porcine endotoxemia is not prevented by ibuprofen. Crit Care Med. 1996, 24 (5): 815-9.
Bernard GR, Wheeler AP, Russell JA, et al: The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997, 336 (13): 912-8. 10.1056/NEJM199703273361303.
Northover BJ, Subramanian G: Analgesics-antipyretics drugs as antagonists of endotoxic shock in dogs. J Pathol Bacteriol. 1962, 83: 463-8.
Rockwell WB, Ehrlich : Ibuprofen in acute-care therapy. Ann Surg. 1990, 211 (1): 78-83.
Kopolovic R, Thrailkill KM, Martin DT, Ambrose T, Vento M, Carey LC, Cloutier CT: Effects of ibuprofen on a porcine model of acute respiratory failure. J Surg Res. 1984, 36 (4): 300-5.
Balk RA, Jacobs RF, Tryka F, Townsed JW, Walls RC, Bone RC: Effects of ibuprofen on neutrophil function and acute lung injury in canine endotoxic shock. Crit Care Med. 1988, 16 (11): 1121-7.
Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parillo JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989, 321 (5): 280-7.
Bernard GR, Reines HD, Halushka PV, et al: Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis. 1991, 144 (5): 1095-1101.
Martich GD, Parker MM, Cunnion RE, Suffredini AF: Effects of ibuprofen and pentoxiphylline on the cardiovascular response of normal humans to endotoxin. J Appl Physiol. 1992, 73 (3): 925-31.
Revhaug A, Michie HR, Manson JM, Watters JM, Dinarello CA, Wolf SM, Willmore DW: Inhibition of cyclo-oxygenase attenuates the metabolic response to the endotoxin in humans. Arch Surg. 1988, 123 (2): 162-170.
Yamanaka S, Iwao H, Yukimura T, Kim S, Miura K: Effect of the thrombocyte-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the hemodynamic changes in canine experimental endotoxic shock. Br J Pharmacol. 1993, 110 (4): 1501-7.
Beck RR, Abel FL: Effect of ibuprofen on the course of canine endotoxin shock. Circ Shock. 1987, 23 (1): 59-70.
Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D: Immunopathologic alterations in murine models of sepsis of increasing severity. Infection and Immunity. 1999, 66 (12): 6603-10.
Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB: Effect of ibuprofen in patients with severe sepsis: a randomized, double-blinded, multicenter study. The Ibuprofen Study Group. Crit Care Med. 1991, 19 (11): 1339-47.
Arons MM, Wheeler AP, Bernard GR, et al: Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med. 1999, 27 (4): 699-707.
Mullen PG, Windsor AC, Walsh CJ, et al: Combined ibuprofen and monoclonal antibody to tumor necrosis factor-alpha attenuate hemodynamic dysfunction and sepsis-induced acute lung injury. J Trauma. 1993, 34 (5): 612-21.
Bjornson AB, Knippenberg RW, Bjornson HS: Nonsteroidal anti-inflammatory drugs correct the bactericidal defect of polymorphonuclear leukocytes in a guinea pig model of thermal injury. J Infect Dis. 1988, 157 (5): 959-67.
Baumgartner JD, Calandra T: Treatment of sepsis: Update on causes and complications. J Crit Ilness. 1999, 7: 1233-54.
Adams T, Traber DL: The effects of a prostaglandin synthetase inhibitor, ibuprofen, on the cardiopulmonary response to endotoxin in sheep. Circ Shock. 1982, 9 (5): 481-9.
Fletcher JR, Collins JN, Graves ED, Luterman A, Williams MD, Izenberg SD: Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. Ann Surg. 1993, 217 (6): 668-75.
Wise WC, Halushka PV, Knapp RG, Cook JA: Ibuprofen, methylprednisolone, and gentamicin as conjoint therapy in septic shock. Circ Shock. 1985, 17 (1): 59-71.
Rosello AM, Ferron-Orihuela JA, Ruiz-Cabello F, Garrote-Lara D, Fernandez-Mondeyar E, Delgado-Carrasco ML: Differential effects of IL-1β and ibuprofen after endotoxic challenge in mice. J Surg Research. 1997, 67 (2): 199-204. 10.1006/jsre.1996.4982.
Vural P, Canbaz M, Akbulut A, Celik I: Effects of ibuprofen on plasma endothelin levels and some vital parameters during endotoxin shock in rabbits. Clin Chim Acta. 2002, 316 (1–2): 101-8. 10.1016/S0009-8981(01)00740-9.
Schirmer WJ, Schirmer JM, Townsed MC, Fry DE: Effects of ibuprofen, indomethacin, and imidazole on survival in sepsis. Curr Surg. 1987, 44 (2): 102-5.
Young JS, Passmore JC: Haemodynamic and renal advantages of dual cyclooxygenase and leukotriene blockade during canine endotoxic shock. Circ Shock. 1990, 32 (3): 243-55.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/2/26/prepub